Ultane Liquid
Product Images NDC 0074-4456

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ultane (NDC 0074-4456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ultane Novaplus Spl 01

Chemical structure diagram of sevoflurane, showing its atomic connections including carbon, hydrogen, oxygen, and fluorine atoms as represented by standard chemical notation.*

FDA Label Image

Ultane Novaplus Spl 02

A line graph depicting the relationship between fresh gas flow rate (L/min) on the x-axis and compound A concentration in parts per million (ppm) on the y-axis. The graph shows a decreasing trend of compound A concentration as the fresh gas flow rate increases from 0 to 4 L/min.*

FDA Label Image

Ultane Novaplus Spl 03

A line chart showing the relationship between carbon dioxide flow in mL/min and two variables: Compound A concentration in ppm and maximum temperature in degrees Celsius. The chart includes two curves, one for Compound A and one for maximum temperature, plotted against increasing carbon dioxide flow rates from 0 to 400 mL/min.*

FDA Label Image

Ultane Novaplus Spl 04

A scatter plot with a linear regression line showing the correlation between Sevoflurane exposure (measured in MAC-Hour) on the x-axis and inspired compound A AUC (ppm-hr) on the y-axis. The graph indicates a strong positive correlation (r = 0.96, p < 0.001).*

FDA Label Image

Ultane Novaplus Spl 05

A line graph comparing the uptake curves of Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide (N2O) over 30 minutes of administration. The y-axis represents the ratio of alveolar concentration to inspired concentration (FA/FI), and the x-axis shows minutes of administration, illustrating their relative rates of onset.*

FDA Label Image

Ultane Novaplus Spl 06

A line graph showing the elimination rates of five inhaled anesthetics: Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide (N2O). The y-axis represents the ratio of alveolar concentration to inspired concentration (FA/FAO) on a logarithmic scale, and the x-axis shows minutes of elimination up to 120 minutes.*

FDA Label Image

Ultane Novaplus Spl 07

A line graph showing serum fluoride concentration (µM) over days post-anesthesia for five inhaled anesthetics: methoxyflurane, sevoflurane, enflurane, isoflurane, and halothane. The x-axis represents days post-anesthesia from pre-anesthesia to 6 days, and the y-axis shows serum fluoride levels from 0 to 70 µM. Methoxyflurane reaches the highest peak, followed by sevoflurane, with enflurane, isoflurane, and halothane having lower levels. Data points include error bars indicating variability, and sample sizes for each anesthetic are noted in the legend.*

FDA Label Image

Ultane Novaplus Spl 08

A line graph depicting mean concentration versus time in hours for Ultane (Sevoflurane). It includes four curves showing mean concentration, mean concentration plus one standard deviation, mean concentration plus two standard deviations, and mean concentration plus three standard deviations over a 48-hour period.*

FDA Label Image

Ultane Novaplus Spl 09

A line graph showing heart rate (beats per minute) on the y-axis against MAC level on the x-axis for Ultane (Sevoflurane) with different gas mixtures. Two lines are graphed: one for Sevoflurane/Oxygen (diamonds) and one for Sevoflurane/Oxygen/Nitrous Oxide (triangles), each with error bars, illustrating heart rate changes at baseline and increasing MAC levels.*

FDA Label Image

Ultane Novaplus Spl 0a

A line graph depicting mmHg values plotted against MAC level, with a baseline mmHg value near 100. Two data series are shown: 'A - Sevo/O2' represented by diamond symbols, and 'C - Sevo/O2/N2O' represented by triangle symbols. Both series demonstrate a decreasing trend in mmHg as MAC level increases from 1 to 2.*

FDA Label Image

Ultane Novaplus Spl 0b

A line graph comparing two groups labeled A (Sevo/O2) and C (Sevo/O2/N2O). The x-axis shows MAC Level from baseline to 2.5, and the y-axis shows a measurement in dyne·sec·cm⁻⁵ ranging from 400 to 1100. Data points with error bars show a decreasing trend for both groups as MAC Level increases.*

FDA Label Image

Ultane Novaplus Spl 0c

A line graph comparing respiratory flow rate (L/min/m²) at various MAC levels of Sevoflurane with different gas mixes: Sevoflurane with O2 and Sevoflurane with O2/N2O. The x-axis represents MAC levels including baseline, and the y-axis shows flow rate from 2 to 7 L/min/m², with data points marked by diamonds and triangles for each gas mix.*

FDA Label Image

Ultane Novaplus Spl 0d

Packaging label for Ultane sevoflurane 250 mL inhalation anesthetic liquid. The label displays the product name Ultane, active ingredient sevoflurane, and the strength of 250 mL. It includes manufacturer information AbbVie Inc. and Novaplus, with origin noted as product of Japan. The label has storage instructions and barcode included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.